The Evolving Landscape of Amyotrophic Lateral Sclerosis Therapies
The battle against amyotrophic lateral sclerosis remains formidable, yet the progression of RADICAVA, RELYVRIO, and emerging pipeline candidates marks a pivotal shift in treatment possibilities
